2010 Hong Kong Reference Framework for Hypertension Care for ...
2010 Hong Kong Reference Framework for Hypertension Care for ... 2010 Hong Kong Reference Framework for Hypertension Care for ...
Module 8Annual AssessmentLaboratory Investigation 1 :Recommended TestsJustificationsGeneral• Urine for protein/ albumin • Detection of hypertensive nephropathy• Uric acid if patient is on diuretic • Detection of Diuretic-inducedhyperuricemia• Optional - Random spot urine albumin:creatinine ratio (ACR)• Detection of hypertensive nephropathyRenal function test• Sodium, Potassium, Urea, Creatinine • Detection of hypertensive nephropathy• Detection of Diuretic-induced electrolytesdisturbanceLipid profiles• Total Cholesterol• Triglyceride• HDL-Cholesterol• LDL-Cholesterol• Detection of concomitant cardiovascularrisk factors• Guidance for antihypertensive and lipidloweringpharmacotherapyManagement:1. Review the risk factors and blood results2. Assess the side effects of drug treatment and manage accordingly3. Inform and encourage patient on lifestyle modifications like salt reduction andexercise4. Explore reasons for non-compliance5. Ensure patient understands nature of hypertension and benefits of long-termtherapy and follow-upHK Reference Framework for Hypertension Care for Adults in Primary Care Settings2
Module 8Annual AssessmentReference:1. HA Clinical Practice Guideline. Management of Hypertension in Primary Care. Hong KongSAR: Hospital Authority; 2008.2. Whitworth JA. 2003 World Health Organization (WHO)/International Societyof Hypertension (ISH) statement on management of hypertension. J Hypertens.2003;21(11):1983-92.3. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. BritishHypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.BMJ. 2004;328(7440):634-40.3 HK Reference Framework for Hypertension Care for Adults in Primary Care Settings
- Page 24 and 25: Chapter 8.Component 3: Clinical Car
- Page 26 and 27: Chapter 9.Component 4: Patient Empo
- Page 28 and 29: Appendix 1. Smoking Cessation Servi
- Page 30 and 31: AcknowledgmentsDr CHU Leung-wingDr
- Page 32 and 33: AcknowledgmentsDr CHAN Wai-manDr Jo
- Page 34 and 35: AcknowledgmentsDr Betty YOUNG Wan-y
- Page 36 and 37: AcknowledgmentsProfessor YU Cheuk-m
- Page 38 and 39: Reference10. Sacks FM, Svetkey LP,
- Page 40 and 41: Module 1 Framework for Population A
- Page 42 and 43: Module 1Framework for Population Ap
- Page 44 and 45: Module 2Blood Pressure Measurement2
- Page 46 and 47: Module 2Blood Pressure Measurement4
- Page 48 and 49: Module 3 Secondary Hypertension 1,2
- Page 50 and 51: Module 4Evaluation for All Newly Di
- Page 52 and 53: Module 4Evaluation for All Newly Di
- Page 54 and 55: Module 5Dietary InterventionFood Gr
- Page 56 and 57: Module 5Dietary InterventionMeals a
- Page 58 and 59: Module 5Dietary InterventionReferen
- Page 60 and 61: Module 6Exercise Recommendations to
- Page 62 and 63: Module 6Exercise Recommendations to
- Page 64 and 65: Module 6Exercise Recommendations to
- Page 66 and 67: Module 7Drug Treatment for People w
- Page 68 and 69: Module 7Drug Treatment for People w
- Page 70 and 71: Module 7Drug Treatment for People w
- Page 72 and 73: Module 7Drug Treatment for People w
Module 8Annual AssessmentLaboratory Investigation 1 :Recommended TestsJustificationsGeneral• Urine <strong>for</strong> protein/ albumin • Detection of hypertensive nephropathy• Uric acid if patient is on diuretic • Detection of Diuretic-inducedhyperuricemia• Optional - Random spot urine albumin:creatinine ratio (ACR)• Detection of hypertensive nephropathyRenal function test• Sodium, Potassium, Urea, Creatinine • Detection of hypertensive nephropathy• Detection of Diuretic-induced electrolytesdisturbanceLipid profiles• Total Cholesterol• Triglyceride• HDL-Cholesterol• LDL-Cholesterol• Detection of concomitant cardiovascularrisk factors• Guidance <strong>for</strong> antihypertensive and lipidloweringpharmacotherapyManagement:1. Review the risk factors and blood results2. Assess the side effects of drug treatment and manage accordingly3. In<strong>for</strong>m and encourage patient on lifestyle modifications like salt reduction andexercise4. Explore reasons <strong>for</strong> non-compliance5. Ensure patient understands nature of hypertension and benefits of long-termtherapy and follow-upHK <strong>Reference</strong> <strong>Framework</strong> <strong>for</strong> <strong>Hypertension</strong> <strong>Care</strong> <strong>for</strong> Adults in Primary <strong>Care</strong> Settings2
Change language